Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades8
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Share Price Information for Faron Pharmaceuticals (FARN)
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals Notes Study Supporting Clevegen Programme
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said an article published in the Journal of Immunology has outlined the functional role of the company's Clever-1 treatment, part of its Clevegen cancer immunotherapy antibody programme.
Faron, which floated in London earlier this month, said the data published in the study supported Clever-1 as an immuosuppresive molecule and supports the use of Clevegen as an immunotherapy product.
"We are working hard to advance our Clevegen programme, as announced recently, towards clinical use as a new onco-immunological alternative," said Faron Chief Executive Markku Jalkanen.
Shares in Faron were trading flat at 275.00 pence on Monday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Latest FARN News
- EXECUTIVE CHANGES: Anglo Pacific promotes investment head to CEO
31 Jan 2022 - Marie-Louise Fjallskog tapped as Faron's new chief medical officer
4 Jan 2022 - Faron appoints Sensei Biotherapeutics's Marie-Louise Fjallskog as CMO
4 Jan 2022 - EXECUTIVE CHANGES: GCP Infrastructure picks Rothschild banker as chair
1 Dec 2021 - TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill
9 Nov 2021 - Faron Pharmaceuticals wins dispute with Rentschler at tribunal
9 Nov 2021 - IN BRIEF: Faron Pharma raises EUR10.5 million in share placing
1 Oct 2021 - IN BRIEF: Faron Pharma to raise at least EUR8 million via placing
30 Sep 2021
Related News
IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki
Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,0...
WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
Faron Pharmaceuticals News
EXECUTIVE CHANGES: Anglo Pacific promotes investment head to CEO
EXECUTIVE CHANGES: Anglo Pacific promotes investment head to CEO
Marie-Louise Fjallskog tapped as Faron's new chief medical officer
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced the appointment of Marie-Louise Fjällskog as ...
Faron appoints Sensei Biotherapeutics's Marie-Louise Fjallskog as CMO
Faron appoints Sensei Biotherapeutics's Marie-Louise Fjallskog as CMO
EXECUTIVE CHANGES: GCP Infrastructure picks Rothschild banker as chair
EXECUTIVE CHANGES: GCP Infrastructure picks Rothschild banker as chair
TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill
TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill
Faron Pharmaceuticals wins dispute with Rentschler at tribunal
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Tuesday that the arbitration tribunal appointed by the ...
IN BRIEF: Faron Pharma raises EUR10.5 million in share placing
IN BRIEF: Faron Pharma raises EUR10.5 million in share placing
IN BRIEF: Faron Pharma to raise at least EUR8 million via placing
IN BRIEF: Faron Pharma to raise at least EUR8 million via placing
Follow the stocks
